Novo Nordisk
Healthcare
Novo Nordisk CEO Defends Ozempic Pricing in Senate Hearing
In a recent Senate testimony, Lars Jørgensen, the CEO of Novo Nordisk, defended the pricing of Ozempic, the company’s widely used medication for...
Healthcare
Study Links Ozempic and Wegovy to Rare Blindness Risk
A recent study published in JAMA Ophthalmology suggests that using Ozempic or Wegovy may elevate the risk of a rare form of blindness...
Healthcare
Weight Loss Drugs May Reduce Bone Density: Study
A recent study published in the journal JAMA Network indicates that medications such as Ozempic and Wegovy, popular for weight loss, may lead...
Healthcare
Wegovy Approved in China, Novo Nordisk Prioritizes Patient Supply
Ozempic manufacturer Novo Nordisk announced on Tuesday that its popular weight loss drug Wegovy has been approved for sale in China. This approval...
